2.03 |
Creating Cancer Killers (runtime: 2:19 min) |
|
The immune system doesn't innately recognize that cancer cells are abnormal, but now researchers can genetically modify a person's own immune cells to attack cancer cells. This type of immunotherapy-a treatment that utilizes the inherent power of the immune system-is increasingly recognized as a promising strategy for the treatment of a variety of cancers. With the help of RetroNectin reagent, Dr. Renier Brentjens reprograms patients' own T cells to recognize a leukemia cell antigen. Returning these engineered cells to patients with relapsed lymphoblastic leukemia can lead to remission. That's Good Science! | ||
页面更新:2021-01-20 09:32:52